Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death....
Main Authors: | José L. Sánchez-Gloria, Horacio Osorio-Alonso, Abraham S. Arellano-Buendía, Roxana Carbó, Adrián Hernández-Díazcouder, Carlos A. Guzmán-Martín, Ivan Rubio-Gayosso, Fausto Sánchez-Muñoz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/4827 |
Similar Items
-
Evaluation of the Health-Promoting Properties of Selected Fruits
by: José A. Figueira, et al.
Published: (2021-07-01) -
Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19
by: Diego Estrada-Luna, et al.
Published: (2022-10-01) -
Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation
by: Young-Su Yi
Published: (2021-01-01) -
New concepts in nutraceuticals as alternative for pharmaceuticals
by: Hamid Nasri, et al.
Published: (2014-01-01) -
Assessment of Techno-Functional and Nutraceutical Potential of Tomato (<i>Solanum lycopersicum</i>) Seed Meal
by: Ramón Maldonado-Torres, et al.
Published: (2020-09-01)